New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.

Microbial transformation of the anti-inflammatory steroid medrysone (1) was carried out for the first time with the filamentous fungi Cunninghamella blakesleeana (ATCC 8688a), Neurospora crassa (ATCC 18419), and Rhizopus stolonifer (TSY 0471). The objective was to evaluate the anti-inflammatory pote...

Full description

Bibliographic Details
Main Authors: Saira Bano, Atia-Tul- Wahab, Sammer Yousuf, Almas Jabeen, Mohammad Ahmed Mesaik, Atta-Ur- Rahman, M Iqbal Choudhary
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4841542?pdf=render
id doaj-d5b9196a541f445b8ab7861ea0280e51
record_format Article
spelling doaj-d5b9196a541f445b8ab7861ea0280e512020-11-25T01:28:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01114e015395110.1371/journal.pone.0153951New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.Saira BanoAtia-Tul- WahabSammer YousufAlmas JabeenMohammad Ahmed MesaikAtta-Ur- RahmanM Iqbal ChoudharyMicrobial transformation of the anti-inflammatory steroid medrysone (1) was carried out for the first time with the filamentous fungi Cunninghamella blakesleeana (ATCC 8688a), Neurospora crassa (ATCC 18419), and Rhizopus stolonifer (TSY 0471). The objective was to evaluate the anti-inflammatory potential of the substrate (1) and its metabolites. This yielded seven new metabolites, 14α-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (2), 6β-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (3), 15β-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (4), 6β,17α-dihydroxy-6α-methylpregn-4-ene-3,11,20-trione (5), 6β,20S-dihydroxy-6α-methylpregn-4-ene-3,11-dione (6), 11β,16β-dihydroxy-6α-methylpregn-4-ene-3,11-dione (7), and 15β,20R-dihydroxy-6α-methylpregn-4-ene-3,11-dione (8). Single-crystal X-ray diffraction technique unambiguously established the structures of the metabolites 2, 4, 6, and 8. Fungal transformation of 1 yielded oxidation at the C-6β, -11β, -14α, -15β, -16β positions. Various cellular anti-inflammatory assays, including inhibition of phagocyte oxidative burst, T-cell proliferation, and cytokine were performed. Among all the tested compounds, metabolite 6 (IC50 = 30.3 μg/mL) moderately inhibited the reactive oxygen species (ROS) produced from zymosan-induced human whole blood cells. Compounds 1, 4, 5, 7, and 8 strongly inhibited the proliferation of T-cells with IC50 values between <0.2-10.4 μg/mL. Compound 7 was found to be the most potent inhibitor (IC50 < 0.2 μg/mL), whereas compounds 2, 3, and 6 showed moderate levels of inhibition (IC50 = 14.6-20.0 μg/mL). Compounds 1, and 7 also inhibited the production of pro-inflammatory cytokine TNF-α. All these compounds were found to be non-toxic to 3T3 cells (mouse fibroblast), and also showed no activity when tested against HeLa (human epithelial carcinoma), or against PC3 (prostate cancer) cancer cell lines.http://europepmc.org/articles/PMC4841542?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Saira Bano
Atia-Tul- Wahab
Sammer Yousuf
Almas Jabeen
Mohammad Ahmed Mesaik
Atta-Ur- Rahman
M Iqbal Choudhary
spellingShingle Saira Bano
Atia-Tul- Wahab
Sammer Yousuf
Almas Jabeen
Mohammad Ahmed Mesaik
Atta-Ur- Rahman
M Iqbal Choudhary
New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
PLoS ONE
author_facet Saira Bano
Atia-Tul- Wahab
Sammer Yousuf
Almas Jabeen
Mohammad Ahmed Mesaik
Atta-Ur- Rahman
M Iqbal Choudhary
author_sort Saira Bano
title New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
title_short New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
title_full New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
title_fullStr New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
title_full_unstemmed New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone.
title_sort new anti-inflammatory metabolites by microbial transformation of medrysone.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Microbial transformation of the anti-inflammatory steroid medrysone (1) was carried out for the first time with the filamentous fungi Cunninghamella blakesleeana (ATCC 8688a), Neurospora crassa (ATCC 18419), and Rhizopus stolonifer (TSY 0471). The objective was to evaluate the anti-inflammatory potential of the substrate (1) and its metabolites. This yielded seven new metabolites, 14α-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (2), 6β-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (3), 15β-hydroxy-6α-methylpregn-4-ene-3,11,20-trione (4), 6β,17α-dihydroxy-6α-methylpregn-4-ene-3,11,20-trione (5), 6β,20S-dihydroxy-6α-methylpregn-4-ene-3,11-dione (6), 11β,16β-dihydroxy-6α-methylpregn-4-ene-3,11-dione (7), and 15β,20R-dihydroxy-6α-methylpregn-4-ene-3,11-dione (8). Single-crystal X-ray diffraction technique unambiguously established the structures of the metabolites 2, 4, 6, and 8. Fungal transformation of 1 yielded oxidation at the C-6β, -11β, -14α, -15β, -16β positions. Various cellular anti-inflammatory assays, including inhibition of phagocyte oxidative burst, T-cell proliferation, and cytokine were performed. Among all the tested compounds, metabolite 6 (IC50 = 30.3 μg/mL) moderately inhibited the reactive oxygen species (ROS) produced from zymosan-induced human whole blood cells. Compounds 1, 4, 5, 7, and 8 strongly inhibited the proliferation of T-cells with IC50 values between <0.2-10.4 μg/mL. Compound 7 was found to be the most potent inhibitor (IC50 < 0.2 μg/mL), whereas compounds 2, 3, and 6 showed moderate levels of inhibition (IC50 = 14.6-20.0 μg/mL). Compounds 1, and 7 also inhibited the production of pro-inflammatory cytokine TNF-α. All these compounds were found to be non-toxic to 3T3 cells (mouse fibroblast), and also showed no activity when tested against HeLa (human epithelial carcinoma), or against PC3 (prostate cancer) cancer cell lines.
url http://europepmc.org/articles/PMC4841542?pdf=render
work_keys_str_mv AT sairabano newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT atiatulwahab newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT sammeryousuf newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT almasjabeen newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT mohammadahmedmesaik newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT attaurrahman newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
AT miqbalchoudhary newantiinflammatorymetabolitesbymicrobialtransformationofmedrysone
_version_ 1725102285808205824